Edesa Biotech (EDSA) Raw Materials (2015)
Edesa Biotech (EDSA) posted Raw Materials of $42549.0 for Q3 2015, up 663.48% sequentially from $5573.0 in Q2 2015.
Edesa Biotech (EDSA) Raw Materials (2015) Analysis & Trends
Edesa Biotech has reported Raw Materials for 1 years, with the latest figure at $42549.0 in Q3 2015.
- Quarterly Raw Materials changed N/A year-over-year to $42549.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $42549.0 (changed N/A YoY) and the FY2015 annual result came in at $42549.0, changed N/A from the prior year.
- Raw Materials climbed to $42549.0 in Q3 2015 per EDSA's latest filing, from $5573.0 in the prior quarter.
- Over five years, Raw Materials peaked at $42549.0 in Q3 2015 and troughed at $5573.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.79 Bn | 130.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 56.04 Bn | 50.91 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.05 Bn | 36.95 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.71 Bn | 28.40 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.66 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.50 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | Edesa Biotech | 40.26 Mn | 40.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 42,549.00 |
| Jun 30, 2015 | 5,573.00 |